Adenovirus 11p downregulates CD46 early in infection

Virology

Volumn 405, Issue 2, 2010, Pages 474-482

  Gustafsson, Dan J ^a   Andersson, Emma K ^a   Hu, Yan Ling ^a   Marttila, Marko ^a   Lindman, Kristina ^a   Strand, Mårten ^a   Wang, Li ^a   Mei, Ya Fang ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

A549 cells; Adenovirus 11p; Adenovirus 7p; CD46; CD55; CD59; Downregulation; K562 cells

Indexed keywords

CD59 ANTIGEN; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN;

ADENOVIRUS; ADENOVIRUS 11; ARTICLE; BINDING AFFINITY; CELL STRAIN K 562; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION;

ADENOVIRUSES, HUMAN; ANTIGENS, CD46; ANTIGENS, CD55; ANTIGENS, CD59; CAPSID PROTEINS; CELL LINE, TUMOR; DOWN-REGULATION; EPITHELIAL CELLS; GENETIC VECTORS; HUMANS; K562 CELLS; LUNG; RECEPTORS, VIRUS;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 11; HUMAN ADENOVIRUS TYPE 7;

EID: 77955662361     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.06.026     Document Type: Article

References (52)

1. Adrian T., Wadell G., Hierholzer J.C., Wigand R. DNA restriction analysis of adenovirus prototypes 1 to 41. Arch. Virol. 1986, 91(3-4):277-290.
2. Ajona D., Hsu Y.F., Corrales L., Montuenga L.M., Pio R. Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth. J. Immunol. 2007, 178(9):5991-5998.
3. Arnberg N. Adenovirus receptors: implications for tropism, treatment and targeting. Rev. Med. Virol. 2009, 19(3):165-178.
4. Astier A.L. T-cell regulation by CD46 and its relevance in multiple sclerosis. Immunology 2008, 124(2):149-154.
5. Benkö M., Harrach B., Russell W.C. Family adenoviridae. Virus Taxonomy 2000, 227-238. Academic Press, Inc, San Diego, CA.
6. Berk A.J. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 2005, 24(52):7673-7685.
7. Bewley M.C., Springer K., Zhang Y.B., Freimuth P., Flanagan J.M. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 1999, 286(5444):1579-1583.
8. Cattaneo R. Four viruses, two bacteria, and one receptor: Membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 2004, 78(9):4385-4388.
9. Choi E.H., Lee H.J., Kim S.J., Eun B.W., Kim N.H., Lee J.A., Lee J.H., Song E.K., Kim S.H. Ten-year analysis of adenovirus type 7 molecular epidemiology in Korea, 1995-2004: Implication of fiber diversity. J. Clin. Virol. 2006, 35(4):388-393.
10. Crimeen-Irwin B., Ellis S., Christiansen D., Ludford-Menting M.J., Milland J., Lanteri M., Loveland B.E., Gerlier D., Russell S.M. Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis. J. Biol. Chem. 2003, 278(47):46927-46937.
11. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity. Science 1996, 271(5247):348-350.
12. Fleischli C., Sirena D., Lesage G., Havenga M.J., Cattaneo R., Greber U.F., Hemmi S. Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on the membrane cofactor protein CD46 receptor. J. Gen. Virol. 2007, 88(Pt 11):2925-2934.
13. Gaggar A., Shayakhmetov D.M., Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 2003, 9(11):1408-1412.
14. Gerlier D., Trescol-Biemont M.C., Varior-Krishnan G., Naniche D., Fugier-Vivier I., Rabourdin-Combe C. Efficient major histocompatibility complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells. J. Exp. Med. 1994, 179(1):353-358.
15. Gerlier D., Trescol-Biemont M.C., Varior-Krishnan G., Naniche D., Fugier-Vivier I., Rabourdin-Combe C. Efficient MHC class II-restricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway. Cell Biol. Int. 1994, 18(5):315-320.
16. Gill D.B., Koomey M., Cannon J.G., Atkinson J.P. Down-regulation of CD46 by piliated Neisseria gonorrhoeae. J. Exp. Med. 2003, 198(9):1313-1322.
17. Gill D.B., Spitzer D., Koomey M., Heuser J.E., Atkinson J.P. Release of host-derived membrane vesicles following pilus-mediated adhesion of Neisseria gonorrhoeae. Cell. Microbiol. 2005, 7(11):1672-1683.
18. Gustafsson D.J., Segerman A., Lindman K., Mei Y.F., Wadell G. The Arg279Gln [corrected] substitution in the adenovirus type 11p (Ad11p) fiber knob abolishes EDTA-resistant binding to A549 and CHO-CD46 cells, converting the phenotype to that of Ad7p. J. Virol. 2006, 80(4):1897-1905.
19. Hong J.S., Engler J.A. Domains required for assembly of adenovirus type 2 fiber trimers. J. Virol. 1996, 70(10):7071-7078.
20. Iacobelli-Martinez M., Nepomuceno R.R., Connolly J., Nemerow G.R. CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines. J. Virol. 2005, 79(17):11259-11268.
21. Jones M.S., Harrach B., Ganac R.D., Gozum M.M., Dela Cruz W.P., Riedel B., Pan C., Delwart E.L., Schnurr D.P. New adenovirus species found in a patient presenting with gastroenteritis. J. Virol. 2007, 81(11):5978-5984.
22. Krantic S., Gimenez C., Rabourdin-Combe C. Cell-to-cell contact via measles virus haemagglutinin-CD46 interaction triggers CD46 downregulation. J. Gen. Virol. 1995, 76(Pt 11):2793-2800.
23. Leen A.M., Rooney C.M. Adenovirus as an emerging pathogen in immunocompromised patients. Br. J. Haematol. 2005, 128(2):135-144.
24. Lozzio B.B., Lozzio C.B., Bamberger E.G., Feliu A.S. A multipotential leukemia cell line (K-562) of human origin. Proc. Soc. Exp. Biol. Med. 1981, 166(4):546-550.
25. Madjd Z., Durrant L.G., Pinder S.E., Ellis I.O., Ronan J., Lewis S., Rushmere N.K., Spendlove I. Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?. Cancer Immunol. Immunother. 2005, 54(2):149-156.
26. Maizel J.V., White D.O., Scharff M.D. The polypeptides of adenovirus: I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 1968, 36(1):115-125.
27. Manalo D., Mufson M.A., Zollar L.M., Mankad V.N. Adenovirus infection in acute hemorrhagic cystitis. A study in 25 children. Am. J. Dis. Child. 1971, 121(4):281-285.
28. Marie J.C., Astier A.L., Rivailler P., Rabourdin-Combe C., Wild T.F., Horvat B. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat. Immunol. 2002, 3(7):659-666.
29. Marttila M., Persson D., Gustafsson D., Liszewski M.K., Atkinson J.P., Wadell G., Arnberg N. CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7. J. Virol. 2005, 79(22):14429-14436.
30. Mei Y.F., Lindman K., Wadell G. Two closely related adenovirus genome types with kidney or respiratory tract tropism differ in their binding to epithelial cells of various origins. Virology 1998, 240(2):254-266.
31. Oksjoki R., Kovanen P.T., Meri S., Pentikainen M.O. Function and regulation of the complement system in cardiovascular diseases. Front. Biosci. 2007, 12:4696-4708.
32. Persson B.D., Reiter D.M., Marttila M., Mei Y.F., Casasnovas J.M., Arnberg N., Stehle T. Adenovirus type 11 binding alters the conformation of its receptor CD46. Nat. Struct. Mol. Biol. 2007, 14(2):164-166.
33. Philipson L., Lonberg-Holm K., Pettersson U. Virus-receptor interaction in an adenovirus system. J. Virol. 1968, 2(10):1064-1075.
34. Ravindranath N.M., Shuler C. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2007, 103(2):231-239.
35. Riley-Vargas R.C., Gill D.B., Kemper C., Liszewski M.K., Atkinson J.P. CD46: expanding beyond complement regulation. Trends Immunol. 2004, 25(9):496-503.
36. Rushmere N.K., Knowlden J.M., Gee J.M., Harper M.E., Robertson J.F., Morgan B.P., Nicholson R.I. Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer. Int. J. Cancer 2004, 108(6):930-936.
37. Russell S. CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function. Tissue Antigens 2004, 64(2):111-118.
38. Sakurai F., Akitomo K., Kawabata K., Hayakawa T., Mizuguchi H. Downregulation of human CD46 by adenovirus serotype 35 vectors. Gene Ther. 2007, 14(11):912-919.
39. Schneider-Schaulies J., Schnorr J.J., Schlender J., Dunster L.M., Schneider-Schaulies S., ter Meulen V. Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells. J. Virol. 1996, 70(1):255-263.
40. Schnorr J.J., Dunster L.M., Nanan R., Schneider-Schaulies J., Schneider-Schaulies S., ter Meulen V. Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells. Eur. J. Immunol. 1995, 25(4):976-984.
41. Segerman A., Mei Y.F., Wadell G. Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines. J. Virol. 2000, 74(3):1457-1467.
42. Segerman A., Atkinson J.P., Marttila M., Dennerquist V., Wadell G., Arnberg N. Adenovirus type 11 uses CD46 as a cellular receptor. J. Virol. 2003, 77(17):9183-9191.
43. Seya T., Hirano A., Matsumoto M., Nomura M., Ueda S. Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions. Int. J. Biochem. Cell Biol. 1999, 31(11):1255-1260.
44. Sirena D., Lilienfeld B., Eisenhut M., Kalin S., Boucke K., Beerli R.R., Vogt L., Ruedl C., Bachmann M.F., Greber U.F., Hemmi S. The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J. Virol. 2004, 78(9):4454-4462.
45. Stevenson S.C., Rollence M., Marshall-Neff J., McClelland A. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J. Virol. 1997, 71(6):4782-4790.
46. Stone D., Ni S., Li Z.Y., Gaggar A., DiPaolo N., Feng Q., Sandig V., Lieber A. Development and assessment of human adenovirus type 11 as a gene transfer vector. J. Virol. 2005, 79(8):5090-5104.
47. Valentine R.C., Pereira H.G. Antigens and structure of the adenovirus. J. Mol. Biol. 1965, 13(1):13-20.
48. Vogels R., Zuijdgeest D., van Rijnsoever R., Hartkoorn E., Damen I., de Bethune M.P., Kostense S., Penders G., Helmus N., Koudstaal W., Cecchini M., Wetterwald A., Sprangers M., Lemckert A., Ophorst O., Koel B., van Meerendonk M., Quax P., Panitti L., Grimbergen J., Bout A., Goudsmit J., Havenga M. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J. Virol. 2003, 77(15):8263-8271.
49. Wadell G., Hammarskjold M.L., Winberg G., Varsanyi T.M., Sundell G. Genetic variability of adenoviruses. Ann. NY Acad. Sci. 1980, 354:16-42.
50. Wang H., Liaw Y.C., Stone D., Kalyuzhniy O., Amiraslanov I., Tuve S., Verlinde C.L., Shayakhmetov D., Stehle T., Roffler S., Lieber A. Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob. J. Virol. 2007, 81(23):12785-12792.
51. Wang H., Liu Y., Li Z.Y., Fan X., Hemminki A., Lieber A. A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy. Blood 2010, 115(3):592-600.
52. Xia D., Henry L., Gerard R.D., Deisenhofer J. Structure of the receptor binding domain of adenovirus type 5 fiber protein. Curr. Top. Microbiol. Immunol. 1995, 199(Pt 1):39-46.